320734-35-8

Basic information

• Product Name: 7-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE
• Synonyms: 7-CHLOROINDOLIN-2-ONE;7-BROMOOXINDOLE;7-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE;7-bromoindolin-2-one;7-Bromo-2-oxindole;7-BroMo-2-oxindole/7-BroMo-1,3-dihydro-2H-indol-2-one;7-Bromo-1,3-dihydro-2H-indol-2-one;7-chloro-2,3-dihydro-1H-indol-2-one
• CAS NO: 320734-35-8
• Molecular Formula: C₈H₆BrNO
• Molecular Weight: 212.04
• EINECS: 1312995-182-4
• Product Categories: blocks;Bromides;IndolesOxindoles;Indoline & Oxindole
• Mol File: 320734-35-8.mol

Chemical Properties

• Melting Point: 194-200°C
• Boiling Point: 358.8 °C at 760 mmHg
• Flash Point: 170.8 °C
• Appearance: /
• Density: 1.666 g/cm³
• Vapor Pressure: 2.48E-05mmHg at 25°C
• Refractive Index: 1.625
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.22±0.20(Predicted)
• CAS DataBase Reference: 7-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE(320734-35-8)
• EPA Substance Registry System: 7-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE(320734-35-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 320734-35-8(Hazardous Substances Data)

Usage

Preparation

STEP A: Preparation of 7-chloro-3-hydrazono-oxindole. A solution of 25.0 g of 7-chloro-isatin in 250 ml of ethanol is refluxed for 24 hours, cooled, and precipitate recovered by filtering and washed once with ethanol and twice with pentane to obtain 7-chloro-3-hydrazono oxindole, m.p. 217-219℃. (decomp.).??STEP B: Preparation of 7-chloro-oxindole. To a solution of sodium ethoxide prepared by heating 5.5 g of sodium in 200 ml. of ethanol at 70°℃. is added 17 g of 7-chloro-3-hydrazono-oxindole over a period of 3.5 hours, and the resulting solution is heated at 70℃. for 24 hours. The solvent is evaporated in vacuo, the residue dissolved in water, acidified with 6 N-hydro chloric acid and the resulting precipitate recovered by filtering, washed three times with water, dried by suc tion and crystallized from methylene chloride/ether to obtain 7-chlorooxindole, 28-220℃.

InChI:InChI=1/C8H6BrNO/c9-6-3-1-2-5-4-7(11)10-8(5)6/h1-3H,4H2,(H,10,11)

Upstream product

• 20780-74-9 7-bromoisatin 
• 400629-31-4 2-(3-bromo-2-nitrophenyl)acetic acid 
• 320734-36-9 4-(7-bromo-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 320734-34-7 4-(7-bromo-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 615-36-1 2-bromoaniline 

Downstream Products

• 400629-20-1 7-[4-(1-methyl-2-{[(methylethyl)sulfonyl]amino}ethyl)phenyl]indolin-2-one 
• 100831-25-2 7-bromo-1-methylindolin-2-one 
• 31676-48-9 7-phenylindolin-2-one 

Relevant articles and documents

Enantioselective construction of the oxidized tryptophan fragment of proteasome inhibitors TMC-95A and TMC-95B

The oxidized tryptophan analogue 5, a proposed intermediate for a synthesis of the proteasome inhibitors TMC-95A and TMC-95B, is prepared using the condensation of oxindole 7 with the (R)-Garner aldehyde and stereoselective dihydroxylation of olefin 6 as key steps. (C) 2000 Elsevier Science Ltd.

Functionalization at Nonperipheral Positions of Triazatruxene: Modular Construction of 1,6,11-Triarylated-Triazatruxenes for Potentially Organic Electronics and Optoelectronics

Functionalization from nonperipheral positions of triazatruxene is representing a challenge. Triarylation of the nonperipheral positions (1, 6, and 11) in triazatruxene scaffold has been achieved for the first time via two approaches. The transformations involve arylation/cyclotrimerization and cyclotrimerization/arylation sequences. POCl3-mediated direct cyclotrimerization of oxindoles containing electron-deficient substituents on the aryl group at the C7-position resulted in the formation of 2-chloroindoles, whereas oxindoles containing electron-donating substituents gave the triazatruxenes. Furthermore, desired triazatruxenes were achieved through cyclotrimerization of 7-bromooxindole followed by coupling with arylboronic acids. NMR structural analysis exhibited that two of the suitably substituted oxindole and triazatuxene may have atropisomerism at room temperature. As a representative triazatruxene scaffold, the optoelectronic properties of 9a have also been studied via ultraviolet-visible (UV-vis) absorption spectra and fluorescence spectra of 9a thin films. Also, density functional theory calculation was realized to get knowledge about frontier molecular orbitals. In the light of the information obtained, an organic light-emitting diode (OLED) device utilizing 9a as an emissive layer was applied to obtain white emission. In brief, this study provides the first examples of the synthesis of triazatruxenes bearing aryl substituents at the nonperipheral positions as candidate compounds for organic electronics, optoelectronics, and material chemistry.

Synthesis of novel 3-(benzothiazol-2-ylmethylene)indolin-2-ones

A mild method for the synthesis of 3-(benzothiazol-2-ylmethylene)indolin-2-ones via the aldol condensation of substituted indolin-2-ones and benzothiazole-2-carbaldehyde is described. This new procedure has significant advantages, such as mild conditions, high yields and simple work-up.

HETEROCYCLIC COMPOUNDS USEFUL AS ANTI-BACTERIAL AGENTS AND METHOD FOR PRODUCTION

The present disclosure relates to compounds of Formula I, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms thereof and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention or suppression of diseases, and conditions mediated by microbes. The present disclosure also relates to the synthesis.and characterization of aforementioned substances.

Selective reduction of carbonyl groups in the presence of low-valent titanium reagents

The chemoselective reduction of several structurally diverse compounds containing carbonyl groups was achieved in the presence of low-valent titanium reagents. This novel synthetic method provides easy access to highly selective reduction of carbonyl groups, and possesses several advantages including one-step procedure, convenient manipulation, good to excellent yields, and short reaction times.

Heterocyclic sulfonamide derivatives

The present invention provides certain heterocyclic sulfonamide derivatives of formula (I): useful for potentiating glutamate receptor function in a patient and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.